T44.8X5A
Billable
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X5A is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X5A is billable and can be used for reimbursement purposes.